The inverse was seen for progression-free survival (PFS) in all women with epithelial ovarian cancer (normal MAGEC3: 16.2 months median versus 24.1 months, log-rank p = 0.002) (Table 1). Here, MAGEC3 is linked to ovarian carcinoma.